Live feed17:02:21·319dSECFilingvia QuantisnowVivos Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Other Events, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.VVOS· Vivos Therapeutics Inc.Health CareOriginal source